This study is looking at whether adding an investigational medicine called XEN1101 to your current treatment may help reduce generalized tonic-clonic seizures.
Participar es tu decisión. Puedes abandonar el estudio en cualquier momento.
Condición
Epilepsia
Para quién es
12 years and older
Visitas
Multiple visits over approximately 7 months
Tiempo requerido
12 semanas
Formato del estudio
In-person study with at-home seizure tracking
Tratamiento del estudio
Proporcionado, sin costo
Compensación
Travel support or reimbursement may be available, depending on your study site.
Tu privacidad
Mantenida privada y segura
Elegibilidad
Si tienes un diagnóstico de esta condición, podrías ser elegible para participar. Esta es una guía sencilla sobre quién puede unirse.
Estas son pautas generales. El equipo del estudio confirma quién puede unirse tras una verificación breve y amistosa.
En palabras sencillas
This study is evaluating whether adding XEN1101 to your current epilepsy medications can help reduce primary generalized tonic-clonic seizures in people whose seizures are not fully controlled. There are no surgeries or implants involved. The study medication is a once-daily capsule taken by mouth, along with routine health checks, seizure tracking, and scheduled clinic visits. While benefits cannot be guaranteed, participating may provide access to a potential new treatment option and help researchers improve care for others living with generalized epilepsy.
El desafío actual
Some people with generalized epilepsy continue to experience tonic-clonic seizures even while taking anti-seizure medications. New treatment options are needed.
Lo que los investigadores esperan aprender
Researchers want to find out whether adding XEN1101 to existing treatment can safely reduce the number of generalized tonic-clonic seizures.
Cómo puede ayudar este tratamiento
If XEN1101 is effective, it may help some people experience fewer seizures and improve their quality of life. However, benefits cannot be guaranteed.
The study team will review your medical history, current medications, and seizure history. You'll complete health checks and record your seizures in a diary.
You will continue taking your regular anti-seizure medications and be randomly assigned to receive either XEN1101 or a placebo capsule once daily with your evening meal.
You may choose to join a separate long-term extension study to continue receiving XEN1101. If not, you'll attend follow-up visits.
1.Learn about the study
Read this page at your own pace. There is no pressure to decide anything today.
2.Answer a few quick questions
A short eligibility questionnaire takes about 5 to 10 minutes.
3.Connect with the study team
A coordinator answers your questions and explains next steps.
4.Review the consent information
You will get clear, written details before you agree to anything.
5.Screening and medical review
Simple checks confirm whether the study is a good fit for you.
6.Confirm you can join
Not eligible? We may help you find other studies that fit you better.
7.Join the study
You start only when you feel ready and have given your consent.
8.Attend visits and track how you feel
The team supports you through every appointment and check-in.
9.Complete follow-up activities
A few final check-ins help the team learn from your experience.
10.Finish the study
You are free to ask questions about your results and what comes next.
Visit the study team on the scheduled dates so they can check how you are doing.
Follow the simple instructions the team gives you for the study treatment.
Note how you feel so the team understands your experience.
Answer a few easy questions about your health and well-being.
El equipo del estudio te explicará cada posible antes de que decidas. Tendrás tiempo para hacer preguntas.
Travel support or reimbursement may be available, depending on your study site.
No. You do not need insurance to take part, and study-related care is provided at no cost to you.
Often yes, but it depends on the study. Share your full medication list with the study team and they will guide you.
Yes. Taking part is your choice, and you can stop at any time for any reason, without affecting your regular care.
You can call or email the study team any time. There is no such thing as a question that is too small.
Yes. Your information is kept private and secure, and only approved people can see your study data.
Toca cualquier palabra para ver su significado en lenguaje sencillo.
Family members and caregivers are welcome to help you decide. You do not have to do this alone.
Prefer we reach out? Request a callback at a time that works for you.
Xenon Pharmaceuticals
Estudio de fase III, aleatorizado, doble ciego y controlado con placebo que evalúa la seguridad, la tolerabilidad y la eficacia de XEN1101 como terapia complementaria en crisis epilépticas de inicio focal.
Epilepsia elegibilidad
Select any one
